| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/05/2008 | EP1007720B1 Dendritic cell hybrids |
| 03/05/2008 | CN101137757A Glycoengineering in mushrooms |
| 03/05/2008 | CN101134964A Production method of recombinant human glandulae parathyroideae (1 to 34 peptide) |
| 03/05/2008 | CN101134963A Cascade expression method of recombinant human glandulae parathyroideae (1 to 34 peptide) |
| 03/05/2008 | CN101134957A High-density highly-effective expression method for recombinant human keratinized cell growth factor-2 |
| 03/05/2008 | CN101134942A Process for producing single-cell protein by employing ocean saccharomycete |
| 03/05/2008 | CN101134924A Method for preparing cigarette spice by using hydrolyzed plant protein |
| 03/05/2008 | CN101134779A Antibodies specific for human CD22 and their therapeutic and diagnostic uses |
| 03/05/2008 | CN101134775A Novel streptococcus antigens |
| 03/05/2008 | CN100372938C Gene encoding labyrinthin, a marker for cancer |
| 03/05/2008 | CN100372925C Method for producing cyclodextrin glucose based transferase and dedicated strain |
| 03/04/2008 | US7339048 Genes encoding genetic stability, gene expression and folding proteins |
| 03/04/2008 | US7339044 Nematode PAN and ZP receptor-like sequences |
| 03/04/2008 | US7339042 cytotoxic fusion proteins that are useful for selectively killing endothelial cells in blood vessels that feed tumors |
| 03/04/2008 | US7339039 Nucleic acids encoding receptor recognition factors, and methods of use thereof |
| 03/04/2008 | US7339038 Heparanase specific molecular probes and their use in research and medical applications |
| 03/04/2008 | US7339037 nucleoside sequence polypeptides; therapy, prevention of influenza viral infections |
| 03/04/2008 | US7339035 Antibody recognizing GM1 ganglioside-bound amyloid β-protein and DNA encoding the antibody |
| 03/04/2008 | US7339033 Pro1481 |
| 03/04/2008 | US7339031 Cancer therapeutics; inhibits protein synthesis on ribosomes |
| 03/04/2008 | US7339030 Human semaphorin L (H-SemaL) and corresponding semaphorins in other species |
| 03/04/2008 | US7338791 Introducing the set of genes into a heterologous host cell, allowing growth of the cells in a suitable medium such that the expression of the genes results in production of enzymes; culturing the cell under conditions permitting the synthesis of the flavonoid by the cells; isolating s flavonoids |
| 03/04/2008 | US7338789 Methods of in vitro protein synthesis |
| 03/04/2008 | US7338785 To generate transgenic, non-human plants or animals or site specific gene modifications in cell lines; fluorescent proteins high through-put screening assays; use as biosensors in prokaryotic and eukaryotic cells, fluorescence activated cell sorting applications, as markers following injection into cells |
| 03/04/2008 | US7338784 Nucleic acids encoding chromophores/fluorophores and methods for using the same |
| 03/04/2008 | US7338783 Nucleic acids encoding chromophores/fluorophores and methods for using the same |
| 03/04/2008 | US7338782 Nucleotide sequences coding polypeptide for use ias diagnostic tool in genetic engineering; proteins that are colored and/or fluorescent, where this feature arises from the interaction of two or more residues of the protein |
| 03/04/2008 | US7338780 Method for producing tripeptides and/or peptides longer than tripeptides |
| 03/04/2008 | US7338779 Genetically modifying the Trichoderma production host in such a way that the microorganism does not produce an essential amount of at least one of the proteins, polypeptides or peptides associated with foam formation during cultivation of the unmodified microorganism |
| 03/04/2008 | US7338772 RF-amide peptides and their use for treating, preventing and curing neurological and metabolic medical disorders. The invention also relates to methods for modulating a G-protein coupled receptor and for identifying substances which modulate |
| 03/04/2008 | US7338770 Using calcitonin precursor protein as diagnostic tool in detection of cancer and sepsis |
| 03/04/2008 | US7338766 Activating adenine triphosphate independent cytolytic modulator for use in the treatment of infection and cancer; generate nutrient broth, propagate microorganisms, allow microorganism to secrete protein, recover protein; inhibiting parasitemia of Plasmodium falciparum |
| 03/04/2008 | US7338759 HCV variants |
| 03/04/2008 | US7338662 Recombinant poxvirus expressing homologous genes inserted into the foxviral genome |
| 03/04/2008 | US7338660 Methods of treating cancer and enhancing immune responses with antibodies that bind CD40 |
| 03/04/2008 | US7338659 Reducing immunogenicities of immunoglobulins by framework-patching |
| 03/04/2008 | US7338658 Chimeric antibody specific to human CD4 which comprises the variable heavy and light chain sequences of an Old World monkey monoclonal antibody produced against human CD4 and human constant heavy and light domain sequences |
| 03/04/2008 | US7338653 Amino-terminally truncated MCP-2 as chemokine antagonists |
| 02/28/2008 | WO2008024769A2 Intensified perfusion production method |
| 02/28/2008 | WO2008024311A2 Purification of low-abundant recombinant proteins from cell culture |
| 02/28/2008 | WO2008024188A2 Dual variable domain immunoglobulin and uses thereof |
| 02/28/2008 | WO2008023689A1 Method of producing fused protein |
| 02/28/2008 | WO2008022401A1 Recombinant hcv e2 glycoprotein |
| 02/28/2008 | US20080051562 polymer conjugated drug contains a recombinant epidermal growth factor (EGF)-like domains and polyethylene glycol; also conjugated with glycolipid, glycoprotein and polysaccharide; as anticoagulants for injured blood vessels |
| 02/28/2008 | US20080051462 Methods for treating genetically-defined proliferative disorders with HSP90 inhibitors |
| 02/28/2008 | US20080051360 Pkc ligands and polynucleotides encoding pkc ligands |
| 02/28/2008 | US20080051356 Truncated 24kDa basic fibroblast growth factor |
| 02/28/2008 | US20080051344 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 02/28/2008 | US20080051338 98 Human Secreted Proteins |
| 02/28/2008 | US20080051336 Relaxin-3 Chimeric Polypeptides and Their Preparation and Use |
| 02/28/2008 | US20080051322 14400, 2838, 14618, 15334, 14274, 32164, 39404, 38911, 26904, 31237, 18057, 16405, 32705, 23224, 27423, 32700, 32712 and 12216, novel seven-transmembrane proteins/G-protein coupled receptors |
| 02/28/2008 | US20080051317 Polypeptides comprising unnatural amino acids, methods for their production and uses therefor |
| 02/28/2008 | US20080051299 DNA-protein fusions and uses thereof |
| 02/28/2008 | US20080050841 Peptides immunoreactive with autoantibodies from patients suffering from rheumatoid arthritis |
| 02/28/2008 | US20080050829 Use of mass spectrometry to detect sepsis |
| 02/28/2008 | US20080050811 Testicular carnitine transporter and its gene |
| 02/28/2008 | US20080050796 Polyketide synthetase activity; vectors; host cells |
| 02/28/2008 | US20080050795 Mixture Of At Least Two Different Antibodies Specific For Predetermined Antigens And Use Of The Mixture |
| 02/28/2008 | US20080050779 Fermentation Process Using Faba Beans as Nitrogen Source |
| 02/28/2008 | US20080050778 Use to identify umami (e.g. MSG) and sweet taste modulatory compounds; e.g. screening for artificial sweeteners |
| 02/28/2008 | US20080050776 Stable mutated pro nerve growth factors |
| 02/28/2008 | US20080050774 Computer-based system for monitoring differential expression; host cells |
| 02/28/2008 | US20080050773 Dipeptide forming enzyme; pharmaceutical and food supplement |
| 02/28/2008 | US20080050772 Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
| 02/28/2008 | US20080050758 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide; cancer detection |
| 02/28/2008 | US20080050745 Sugar chain synthesizing agent having beta1,3-N-acetyglucosaminyltransferase activity |
| 02/28/2008 | US20080050470 Cacao endoproteinases and production of cocoa flavor from same |
| 02/28/2008 | US20080050405 Ringworm Vaccine |
| 02/28/2008 | US20080050402 comprising replacements in the influenza nonstructural 1 (NS1) polypeptide, that interferes with viral replication and phosphatidylinositol 3-kinase activation, used for treating and preventing influenza virus infection |
| 02/28/2008 | US20080050399 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/28/2008 | US20080050396 useful in vaccine compositions for treatment of cancer; human major histocompatibility complex (MHC) Class I restricted peptides; kits |
| 02/28/2008 | US20080050393 Novel nucleic acids and polypeptides |
| 02/28/2008 | US20080050388 Specified complementary determining region (CRD) amino acid sequences; specific binding activity for a cryptic collagen epitope; angiogenesis inhibition, antimetastasis, and tumor-targeted therapy uses |
| 02/28/2008 | US20080050386 Novel proteins, gene encoding the same and method of utilization thereof |
| 02/28/2008 | US20080050374 Immunoglobulin fusion for prevention and treatment of cell proliferative disorders |
| 02/28/2008 | US20080050371 Comprises immunoglobulin for treating and preventing inflammation, thrombocytopenia and/or autoimmune hemolytic anemia |
| 02/28/2008 | US20080050370 Stabilized polypeptide compositions |
| 02/28/2008 | US20080050369 Therapeutic applications of T-BAM (CD40L) technology to treat diseases involving smooth muscle cells |
| 02/28/2008 | US20080050366 Neutralizing antibodies and methods of use thereof |
| 02/28/2008 | US20080050365 Anti-Hiv Antibody |
| 02/28/2008 | US20080050363 Novel nucleic acid molecules encoding opioid growth factor receptors |
| 02/28/2008 | US20080050359 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 02/28/2008 | US20080050345 Adeno-associated virus serotype I nucleic acid sequences, vectors and host cells containing same |
| 02/28/2008 | US20080050310 Antibodies and immunoconjugates and uses therefor |
| 02/28/2008 | US20080048052 Spray Nozzle Apparatus and Method of Use |
| 02/28/2008 | CA2661814A1 Recombinant hcv e2 glycoprotein |
| 02/27/2008 | EP1892299A2 Sense mRNA therapy |
| 02/27/2008 | EP1892296A1 Generation and selection of recombinant varied binding proteins |
| 02/27/2008 | EP1892251A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/27/2008 | EP1891108A1 Psp94 diagnostic reagents and assays |
| 02/27/2008 | EP1891092A2 Incorporation of non-naturally encoded amino acids into proteins |
| 02/27/2008 | EP1670897A4 Igf-1 instructs multipotent adult cns neural stem cells to an oligodendroglial lineage |
| 02/27/2008 | EP1341811B1 Orally ingestible preparation of mistletoe lectins and method |
| 02/27/2008 | EP1261723B1 Hybrid expression of neisserial proteins |
| 02/27/2008 | EP1071714B1 A novel g-protein coupled receptor |
| 02/27/2008 | EP0942968B1 Fully human antibodies that bind EGFR |
| 02/27/2008 | EP0739350B1 Ligand that binds fas antigen |
| 02/27/2008 | CN101133083A 人源化的抗cd47抗体 Humanized anti-cd47 antibody |
| 02/27/2008 | CN101130801A Preparation of active antihypertensive peptide product |
| 02/27/2008 | CN101130800A Method for preparing antihypertensive peptide by enzymolysis of hairtail chine |